These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995 [TBL] [Abstract][Full Text] [Related]
3. Naturally occurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus and macroglobulinemia. I. Purification and immunologic studies. Harisdangkul V; McDougal JS; Knapp M; Christian CL J Immunol; 1975 Jul; 115(1):216-22. PubMed ID: 807624 [TBL] [Abstract][Full Text] [Related]
4. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases]. Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to dsDNA and ssDNA in the immunoglobulin classes IgG and IgM: prognostic value in the course of SLE. Krippner H; Merle S; Jörgens K; Pirlet K Z Rheumatol; 1984; 43(5):265-71. PubMed ID: 6335329 [TBL] [Abstract][Full Text] [Related]
7. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE? Al Attia HM Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159 [TBL] [Abstract][Full Text] [Related]
9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
10. [Systemic lupus erythematosus in children with renal and hematologic manifestations. Relation to anti-nDNA antibodies]. Martínez-Cordero E; Riebeling-Navarro CG; López-Zepeda J; Martínez-Miranda E; Negrete-García MC Bol Med Hosp Infant Mex; 1989 Jan; 46(1):11-21. PubMed ID: 2785391 [TBL] [Abstract][Full Text] [Related]
11. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
12. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [TBL] [Abstract][Full Text] [Related]
13. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related]
14. The significance of platelet-associated immunoglobulin G in non-thrombocytopenic patients with systemic lupus erythematosus. Sørensen PG; Mickley H; Fristed P; Diederichsen H Dan Med Bull; 1985 Aug; 32(4):233-7. PubMed ID: 3899527 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471 [TBL] [Abstract][Full Text] [Related]
16. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
18. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
19. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818 [TBL] [Abstract][Full Text] [Related]
20. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]